Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03689699
Title Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Charles G. Drake
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Winship Cancer Institute, Emory University Atlanta Georgia 30322 United States Details
Weill Cornell Medical Center New York New York 10021 United States Details
Columbia University Irving Medical Center New York New York 10032 United States Details
Sidney Kimmel Cancer Center- Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field